MCM
OM icon

Massar Capital Management’s Outset Medical OM Stock Holding History

Massar Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,000
Closed -$384K – 202
2025
Q2 		$384K Buy
+20,000
New +$312K 0.29% 77

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Massar Capital Management's OM Position: Q3 2025 in Review

Massar Capital Management sold out of Outset Medical (OM) in Q3 2025, closing a stake of 20,000 shares — an estimated $384K sold.

Massar Capital Management first reported a position in OM in Q2 2025 and held it in 1 quarter. The position peaked at $384K in Q2 2025. 101 funds tracked by Wall St. Rank hold OM as of Q3 2025.

  • Massar Capital Management reported no remaining Outset Medical position as of Q3 2025 after selling out during the quarter.
  • Massar Capital Management sold 20,000 Outset Medical shares in Q3 2025, an estimated $384K.
  • Massar Capital Management first reported a position in Outset Medical in Q2 2025 and held it in 1 quarter.
  • Massar Capital Management's Outset Medical position peaked at $384K in Q2 2025.
  • 101 funds tracked by Wall St. Rank held Outset Medical as of Q3 2025.

Based on Massar Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.